Recent Advances in Oral Peptide or Protein-Based Drug Liposomes.
Quick Facts
What This Study Found
Improved liposome formulations can enhance the stability and absorption of peptide drugs.
Key Numbers
How They Did This
The article reviews various strategies for liposome preparation and surface modification.
Why This Research Matters
Enhancing the oral bioavailability of peptide drugs can lead to more effective treatments and improved patient compliance. This research could pave the way for new oral medications.
What This Study Doesn't Tell Us
The review does not provide experimental data but rather summarizes existing strategies.
Trust & Context
- Original Title:
- Recent Advances in Oral Peptide or Protein-Based Drug Liposomes.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 15(9) (2022)
- Authors:
- Cui, Jian, Wen, Zhiwei, Zhang, Wei(11), Wu, Wei
- Database ID:
- RPEP-06066
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06066APA
Cui, Jian; Wen, Zhiwei; Zhang, Wei; Wu, Wei. (2022). Recent Advances in Oral Peptide or Protein-Based Drug Liposomes.. Pharmaceuticals (Basel, Switzerland), 15(9). https://doi.org/10.3390/ph15091072
MLA
Cui, Jian, et al. "Recent Advances in Oral Peptide or Protein-Based Drug Liposomes.." Pharmaceuticals (Basel, 2022. https://doi.org/10.3390/ph15091072
RethinkPeptides
RethinkPeptides Research Database. "Recent Advances in Oral Peptide or Protein-Based Drug Liposo..." RPEP-06066. Retrieved from https://rethinkpeptides.com/research/cui-2022-recent-advances-in-oral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.